Lidocaine Infusion in Hystroscopy

A

Ain Shams University

Status and phase

Completed
Phase 2

Conditions

Pain

Treatments

Drug: Lidocaine Hydrochloride
Drug: Diclofenac Sodium

Study type

Interventional

Funder types

Other

Identifiers

NCT03825016
AS1855

Details and patient eligibility

About

Lidocaine infusion in hystroscopic media versus oral diclofenac

Enrollment

44 patients

Sex

Female

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 18-35 years
  • BMI 18.5-30 kg/m2
  • Diagnostic hystroscope

Exclusion criteria

  • Previous cervical surgery
  • Cervical stenosis
  • PID
  • allergy to NSAID
  • Gastritis or peptic ulcer

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

44 participants in 2 patient groups

Lidocaine
Experimental group
Description:
Lidocaine Hydrochloride
Treatment:
Drug: Lidocaine Hydrochloride
Diclofenac
Experimental group
Description:
Oral Diclofenac
Treatment:
Drug: Diclofenac Sodium

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems